Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	1100	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	1132	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	1339	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	1598	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	1717	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	1876	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	1877	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	1964	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	2052	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	2142	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	2170	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	2643	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	2650	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	2755	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	2825	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	2826	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	3016	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	3194	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	4217	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	4629	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	4676	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-	6405	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1020	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1065	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1092	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1110	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1112	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1190	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1199	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1508	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1577	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1671	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1681	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	1916	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2001	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2065	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2087	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2117	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2144	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2356	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2833	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2838	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2874	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	2904	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	3443	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	3543	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	3874	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	3976	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	3998	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	4650	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	4671	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	8133	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+	21467	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	1398	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	3462	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	4402	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	4453	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	4541	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	4783	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	5145	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	5268	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	5425	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	5582	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	5721	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	5792	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	5909	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	5916	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	6048	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	6093	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	6417	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	6443	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	6824	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7047	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7171	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7329	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7337	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7373	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7657	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7684	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7731	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7919	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7930	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	7945	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	8035	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	8141	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	8183	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	8219	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	8252	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	8293	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	8326	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	8425	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	8447	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	9177	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	9546	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	9727	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	9745	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	10219	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	10278	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	10317	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	10675	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	10690	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	10787	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	10850	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	10936	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	10965	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	11015	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	11446	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	11627	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	12649	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	13571	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	14030	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	15460	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	15474	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	16165	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	16404	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	17057	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	17223	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	18451	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	22569	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O]	26783	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y

Return to search page